These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 8820793)

  • 21. [Topical hormonal treatment and urogenital atrophy].
    Sitruk-Ware R; Thomas JL
    Praxis (Bern 1994); 1997 Aug; 86(33):1245-8. PubMed ID: 9381009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urogenital symptoms of postmenopausal women in Turkey.
    Bozkurt N; Ozkan S; Korucuoğlu U; Onan A; Aksakal N; Ilhan M; Himmetoğlu O
    Menopause; 2007; 14(1):150-6. PubMed ID: 17075431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of low-dose intravaginal estriol on urogenital aging in postmenopausal women.
    Dessole S; Rubattu G; Ambrosini G; Gallo O; Capobianco G; Cherchi PL; Marci R; Cosmi E
    Menopause; 2004; 11(1):49-56. PubMed ID: 14716182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of estrogen supplementation in lower urinary tract dysfunction.
    Hextall A; Cardozo L
    Int Urogynecol J Pelvic Floor Dysfunct; 2001; 12(4):258-61. PubMed ID: 11569655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary incontinence and urinary tract infections in octogenarian women.
    Björnsdóttir LT; Geirsson RT; Jónsson PV
    Acta Obstet Gynecol Scand; 1998 Jan; 77(1):105-9. PubMed ID: 9492729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Special considerations in premenopausal and postmenopausal women with symptoms of overactive bladder.
    Cardozo L; Robinson D
    Urology; 2002 Nov; 60(5 Suppl 1):64-71; discussion 71. PubMed ID: 12493358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The postmenopausal bladder.
    Hillard T
    Menopause Int; 2010 Jun; 16(2):74-80. PubMed ID: 20729499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of postmenopausal vaginal atrophy with 10-μg estradiol vaginal tablets.
    Panay N; Maamari R
    Menopause Int; 2012 Mar; 18(1):15-9. PubMed ID: 22393176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the Hormones and Urogenital Therapy Committee.
    Cardozo L; Bachmann G; McClish D; Fonda D; Birgerson L
    Obstet Gynecol; 1998 Oct; 92(4 Pt 2):722-7. PubMed ID: 9764689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Long-term use of ovestin by postmenopausal women with urinary incontinence].
    D'iakov VV; Godunov BN; Gvozdev MIu
    Urologiia; 2003; (1):43-6. PubMed ID: 12621967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparative study of the effects of local estrogen with or without local testosterone on vulvovaginal and sexual dysfunction in postmenopausal women.
    Raghunandan C; Agrawal S; Dubey P; Choudhury M; Jain A
    J Sex Med; 2010 Mar; 7(3):1284-90. PubMed ID: 20102444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical vaginal estrogen therapy in managing postmenopausal urinary symptoms: a reality or a gimmick?
    Ewies AA; Alfhaily F
    Climacteric; 2010 Oct; 13(5):405-18. PubMed ID: 20670198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of an orally administered combination of hyaluronic acid, chondroitin sulfate, curcumin and quercetin for the prevention of recurrent urinary tract infections in postmenopausal women.
    Torella M; Del Deo F; Grimaldi A; Iervolino SA; Pezzella M; Tammaro C; Gallo P; Rappa C; De Franciscis P; Colacurci N
    Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():125-128. PubMed ID: 27838537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The development of a quality of life instrument for use with post-menopausal women with urogenital atrophy in the UK and Sweden.
    McKenna SP; Whalley D; Renck-Hooper U; Carlin S; Doward LC
    Qual Life Res; 1999 Aug; 8(5):393-8. PubMed ID: 10474280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect and safety of 17 beta-estradiol vaginal tablet in postmenopausal women with urogenital symptoms.
    Manonai J; Theppisai U; Chittacharoen A
    J Med Assoc Thai; 2001 Jul; 84(7):1015-20. PubMed ID: 11759960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estrogens and the urogenital tract. Studies on steroid hormone receptors and a clinical study on a new estradiol-releasing vaginal ring.
    Smith P
    Acta Obstet Gynecol Scand Suppl; 1993; 157():1-26. PubMed ID: 8393609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urogenital atrophy.
    Calleja-Agius J; Brincat MP
    Climacteric; 2009 Aug; 12(4):279-85. PubMed ID: 19387880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The management of lower urogenital changes in the menopause.
    Singh S; van Herwijnen I; Phillips C
    Menopause Int; 2013 Jun; 19(2):77-81. PubMed ID: 23778562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized comparison of tolterodine with vaginal estrogen cream versus tolterodine alone for the treatment of postmenopausal women with overactive bladder syndrome.
    Tseng LH; Wang AC; Chang YL; Soong YK; Lloyd LK; Ko YJ
    Neurourol Urodyn; 2009; 28(1):47-51. PubMed ID: 19089890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of urinary incontinence in a prospective cohort of postmenopausal women.
    Jackson SL; Scholes D; Boyko EJ; Abraham L; Fihn SD
    Obstet Gynecol; 2006 Oct; 108(4):855-62. PubMed ID: 17012446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.